Cytrx Corporation

San Diego, CA 92109

SBIR Award Summary

Total Number of Awards 7
Total Value of Awards $517K
First Award Date 09/15/96
Most Recent Award Date 09/20/06

Key Personnel

Last Name Name Awards Contact
Jagannath Chinnaswamy Jagannath 1
Emanuele R M Emanuele 2
Pillion Dennis J Pillion 3
Skiles Jerry W Skiles 1

7 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-06
Budget: 09/20/06 - 08/31/07

DESCRIPTION (provided by applicant): Project Summary/Abstract: Type 2 diabetes (T2D) and obesity are major health concerns that have been increasing at an alarming rate over the last few decades resulting in costs to the medical system upwards of $100 billion annually in related medical expenses. Fatty acid synthase (FAS-1) is a key enzyme in ma...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/00 - 05/31/02

Nasal insulin delivery remains a possible alternative for patients with diabetes mellitus in attempting to control blood glucose levels. Nasal insulin administration requires the addition of a surfactant agent to improve systemic absorption of insulin, but this requirement has led to difficulty in identifying safe, effective surfactant agents th...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/00 - 05/31/02

Nasal insulin delivery remains a possible alternative for patients with diabetes mellitus in attempting to control blood glucose levels. Nasal insulin administration requires the addition of a surfactant agent to improve systemic absorption of insulin, but this requirement has led to difficulty in identifying safe, effective surfactant agents th...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/99 - 09/29/00

Nasal insulin delivery remains a possible alternative for patients with diabetes mellitus in attempting to control blood glucose levels. Nasal insulin administration requires the addition of a surfactant agent to improve systemic absorption of insulin, but this requirement has led to difficulty in identifying safe, effective surfactant agents th...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/98 - 02/29/00

Studies in Phase I demonstrated that CRL 1072 is effective against acute infection with Mycobacterium Avium (MAI) in combination with clarithromycin, rifabutin and clindamycin. The goal of Phase II is to recommend a specific combination of drugs in specific dosage forms that will effectively treat ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/97 - 08/31/98

Studies in Phase I demonstrated that CRL 1072 is effective against acute infection with Mycobacterium Avium (MAI) in combination with clarithromycin, rifabutin and clindamycin. The goal of Phase II is to recommend a specific combination of drugs in specific dosage forms that will effectively treat ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/15/96 - 03/14/97